Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QLT PhotoTherapeutics (QLTI) -- Ignore unavailable to you. Want to Upgrade?

To: Ian@SI who wrote (392)	1/9/1999 8:25:00 PM
From: Ian@SI	Read Replies (2) \| Respond to of 1321

I listened to the CBC interview between Christeen Pochmursky and Julia Levy, QLT's President and CEO. It started with a description of ARMD and Visudyne's role in treating that disease. Included Julia's estimates of the number of new cases annually in North America and Worldwide. Worldwide was only 2 1/2 times the North American use. Unless I'm more mathematically challenged than I think, this must be a gross underestimate of the number of new cases annually. ... unless she was trying to estimate the number of people who might be able to afford the treatment in its early years of release. She then discussed the remaining approval steps and time table for introducing it to the world. All in all, a good interview. I have recorded the Audio using PureVoice - a free voice Email program developed by Qualcomm. If anyone wants the voice file (and a URL from where you can get the free PureVoice Player), just click on my name above; then send me a private message or Email letting me know what Email address you want the voice file sent to. Ian.